GEMITERO gemcitabine (as hydrochloride) 200 mg powder for injection vial

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

gemcitabine hydrochloride, Quantity: 228 mg

Tersedia dari:

Hetero Australia Pty Ltd

INN (Nama Internasional):

Gemcitabine hydrochloride

Bentuk farmasi:

Injection, powder for

Komposisi:

Excipient Ingredients: mannitol; sodium hydroxide; sodium acetate trihydrate

Rute administrasi :

Intravenous Infusion

Unit dalam paket:

1 vial

Jenis Resep:

(S4) Prescription Only Medicine

Indikasi Terapi:

Gemcitabine is indicated for treatment of patients with locally advanced or metastatic non- small cell lung cancer.,Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine is also indicated for patients with 5-FU refractory pancreatic cancer.,Gemcitabine, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer.,Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.,Gemcitabine, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum? based therapy

Ringkasan produk:

Visual Identification: White to off-white lyophilised powder to be reconstituted for intravenous use.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Status otorisasi:

Licence status A

Tanggal Otorisasi:

2015-03-03